HABA Laboratories, Inc. Financial Overview
HABA Laboratories, Inc.'s market cap is currently ¥6.32B. The company's EPS TTM is ¥38.84; its P/E ratio is 8.12; and it has a dividend yield of 2.39%. HABA Laboratories, Inc. is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
